Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

This is a de-identified dataset accompanying the Nature Medicine publication titled "Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial", by Vos et al. (DOI: https://doi.org/10.1038/s41591-023-02518-x). It contains the clinical features and processed data of 64 patients with salivary gland cancer, treated with nivolumab and ipilimumab immunotherapy. These data underlie results reported in the article. Raw whole-exome and RNA sequencing data generated in this study have been made publicly available at SRA under BioProject number PRJNA940989.